Crozer-Keystone Regional Cancer Center at Broomall is a clinical research site located in Broomall, Pennsylvania, United States 19008.
Crixeo Health Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.
Crozer-Keystone Regional Cancer Center at Broomall has participated in 28 clinical trials with 18 currently active.
Therapeutic areas: Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7, Stage IIIA Lung Non-Small Cell Cancer AJCC v7.
Sponsors: National Cancer Institute (NCI), SWOG Cancer Research Network, NRG Oncology.
Trust Score: 79/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Crozer-Keystone Regional Cancer Center at Broomall has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Crozer-Keystone Regional Cancer Center at Broomall has 28 clinical trials on record, with 18 currently active. Their work covers Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7, Stage IIIA Lung Non-Small Cell Cancer AJCC v7.
Yes — Crozer-Keystone Regional Cancer Center at Broomall holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.